NCT04621253View on ClinicalTrials.gov

Inhibition Metamizole 2020

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 29, 2020

Primary Completion Date

October 2, 2020

Study Completion Date

October 2, 2020

Conditions
Drug-drug Interaction
Interventions
DRUG

Novalgin

Single dose of 1000 mg metamizole, 1h after the last inhibitor or placebo intake

Trial Locations (1)

4000

University Hospital, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT04621253 - Inhibition Metamizole 2020 | Biotech Hunter | Biotech Hunter